Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-055691
Filing Date
2007-03-15
Accepted
2007-03-15 16:33:28
Documents
11
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 933978
2 AMENDED AND RESTATED 2005 EMPLOYMENT COMMENCEMENT INCENTIVE PLAN dex1031.htm EX-10.31 131176
3 AMENDED AND RESTATED 2006 EMPLOYMENT COMMENCEMENT INCENTIVE PLAN dex1032.htm EX-10.32 133197
4 AMENDMENT OF MARLENE F. PERRY EMPLOYMENT COMMENCEMENT NONSTATUTORY STOCK OPTION dex1036.htm EX-10.36 8992
5 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 2007
6 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 7852
7 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 7911
8 SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 4028
9 SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 3964
10 GRAPHIC g30688g09n32.jpg GRAPHIC 31928
11 GRAPHIC g30688g41d76.jpg GRAPHIC 37476
  Complete submission text file 0001193125-07-055691.txt   1330412
Mailing Address TWO CORPORATE DR SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DR SOUTH SAN FRANCISCO CA 94080 650-266-1400
RENOVIS INC (Filer) CIK: 0001118361 (see all company filings)

EIN.: 943353740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50564 | Film No.: 07696810
SIC: 2834 Pharmaceutical Preparations